Literature DB >> 15550680

The aryl hydrocarbon receptor predisposes hepatocytes to Fas-mediated apoptosis.

Kyung-Tae Park1, Kristen A Mitchell, Gengming Huang, Cornelis J Elferink.   

Abstract

Liver homeostasis is achieved by the removal of diseased and damaged hepatocytes and their coordinated replacement to maintain a constant liver cell mass. Cirrhosis, viral hepatitis, and toxic drug effects can all trigger apoptosis in the liver as a means of removing the unwanted cells, and the Fas "death receptor" pathway comprises a major physiological mechanism by which this occurs. The susceptibility to Fas-mediated apoptosis is, in part, a function of the hepatocyte's proteome. The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor known to influence apoptosis, conceivably by regulating the expression of genes involved in apoptotic signaling. In this article, we present evidence demonstrating that AhR expression and function promote apoptosis in liver cells in response to Fas stimulation. Reintroduction of the AhR into the AhR-negative BP8 hepatoma cells as well as into primary hepatocytes from AhR knockout mice increases the magnitude of cell death in response to Fas ligand. Enhanced apoptosis correlates with increased caspase activity and mitochondrial cytochrome c release but not with the expression of several Bcl-2 family proteins. In vivo studies showed that in contrast to wild-type mice, AhR knockout mice are protected from the lethal effects of the anti-Fas Jo2 antibody. Moreover, down-regulation of the aryl hydrocarbon receptor nuclear translocator protein in vivo by adenovirus-mediated RNA interference to suppress AhR activity provided wild-type mice partial protection from Jo2-induced lethality.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15550680     DOI: 10.1124/mol.104.005223

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  22 in total

Review 1.  Regulation of constitutive and inducible AHR signaling: complex interactions involving the AHR repressor.

Authors:  Mark E Hahn; Lenka L Allan; David H Sherr
Journal:  Biochem Pharmacol       Date:  2008-09-20       Impact factor: 5.858

2.  A novel nonconsensus xenobiotic response element capable of mediating aryl hydrocarbon receptor-dependent gene expression.

Authors:  Gengming Huang; Cornelis J Elferink
Journal:  Mol Pharmacol       Date:  2011-11-23       Impact factor: 4.436

Review 3.  The potential for chemical mixtures from the environment to enable the cancer hallmark of sustained proliferative signalling.

Authors:  Wilhelm Engström; Philippa Darbre; Staffan Eriksson; Linda Gulliver; Tove Hultman; Michalis V Karamouzis; James E Klaunig; Rekha Mehta; Kim Moorwood; Thomas Sanderson; Hideko Sone; Pankaj Vadgama; Gerard Wagemaker; Andrew Ward; Neetu Singh; Fahd Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Anna Maria Colacci; Monica Vaccari; Chiara Mondello; A Ivana Scovassi; Jayadev Raju; Roslida A Hamid; Lorenzo Memeo; Stefano Forte; Rabindra Roy; Jordan Woodrick; Hosni K Salem; Elizabeth P Ryan; Dustin G Brown; William H Bisson
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

Review 4.  Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesis.

Authors:  Zhiwei Hu; Samira A Brooks; Valérian Dormoy; Chia-Wen Hsu; Hsue-Yin Hsu; Liang-Tzung Lin; Thierry Massfelder; W Kimryn Rathmell; Menghang Xia; Fahd Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Dustin G Brown; Kalan R Prudhomme; Annamaria Colacci; Roslida A Hamid; Chiara Mondello; Jayadev Raju; Elizabeth P Ryan; Jordan Woodrick; A Ivana Scovassi; Neetu Singh; Monica Vaccari; Rabindra Roy; Stefano Forte; Lorenzo Memeo; Hosni K Salem; Leroy Lowe; Lasse Jensen; William H Bisson; Nicole Kleinstreuer
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

5.  Protective effects of HFE7A, mouse anti-human/mouse Fas monoclonal antibody against acute and lethal hepatic injury induced by Jo2.

Authors:  Hiroko Yoshida; Kenji Watanabe; Shu Takahashi; Kimihisa Ichikawa
Journal:  Cytotechnology       Date:  2009-12-19       Impact factor: 2.058

6.  Synergistic inhibition of hepatocellular carcinoma growth by cotargeting chromatin modifying enzymes and poly (ADP-ribose) polymerases.

Authors:  Jun-Xiang Zhang; Da-Qiang Li; Aiwu Ruth He; Mona Motwani; Vasilis Vasiliou; Jeyanthy Eswaran; Lopa Mishra; Rakesh Kumar
Journal:  Hepatology       Date:  2012-06       Impact factor: 17.425

7.  Regulation of the activity and expression of aryl hydrocarbon receptor by ethanol in mouse hepatic stellate cells.

Authors:  Hong Feng Zhang; Xing Hua Lin; Hong Yang; Li Chun Zhou; Yang Lin Guo; Joey V Barnett; Zhong Mao Guo
Journal:  Alcohol Clin Exp Res       Date:  2012-04-06       Impact factor: 3.455

Review 8.  Role of AhR in positive regulation of cell proliferation and survival.

Authors:  Jiuheng Yin; Baifa Sheng; Yuan Qiu; Kunqiu Yang; Weidong Xiao; Hua Yang
Journal:  Cell Prolif       Date:  2016-08-14       Impact factor: 6.831

Review 9.  Activation of the aryl hydrocarbon receptor by TCDD inhibits senescence: a tumor promoting event?

Authors:  S Ray; H I Swanson
Journal:  Biochem Pharmacol       Date:  2008-11-27       Impact factor: 5.858

10.  Identification of stanniocalcin 2 as a novel aryl hydrocarbon receptor target gene.

Authors:  Tod A Harper; Aditya D Joshi; Cornelis J Elferink
Journal:  J Pharmacol Exp Ther       Date:  2012-12-26       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.